Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

EU project for the development of Crimean-Congo Haemorrhagic Fever virus (CCHFV) vaccines starts

27.01.2017

On 25 and 26 January the CCHFVaccine kick-off meeting took place at the Paul-Ehrlich-Institut. CCHFVaccine is a multinational and interdisciplinary research project. This consortium will investigate model vaccines against Crimean-Congo haemorrhagic fever for the protection of humans and animals. The Paul-Ehrlich-Institut and the Friedrich-Loeffler-Institut are among the 14 partners involved and will support the project with its regulatory expertise as well as Biosafety Level 4 experimental capacity.

Crimean-Congo haemorrhagic fever is cause by the Crimean-Congo haemorrhagic virus (CCHFV). Ruminants constitute the primary viral reservoir. CCHFV is wide-spread and occurs in various countries in Europe, Asia, the Middle East, and Africa. The virus is transmitted by ticks and the close contact with infected blood or tissue.


Transmission cycle of Crimean Congo Haemorrhagic fever virus (CCHFV)

Source:CCHF Vaccine

Infected animals generally do not show any signs of disease, whereas patients develop flu-like symptoms with fever, muscle and limb ache, as well as neurological and gastrointestinal signs. A subset of those affected develop serious haemorrhagies, and the mortality rate lies around 30 percent. Up to now, neither effective antiviral treatments nor licensed vaccines are available.

The CCHFVaccine Project aims at stepping up efforts to develop and provide vaccines against CCHFV for humans and animals thereby using an One Health approach as already exemplified by the participation of both major German medical and veterinary infectious disease research institutes.

Vaccination of susceptible animals will be pursued to reduce the viral burden, whereas vaccine development for humans primarily aims at the protection of individuals at high risk for exposure. The project consortium is funded with six million € for a period of six years within the scope of the European research and innovation programme "Horizon 2020" (see below).

The CCHFVaccine Consortium is led by Professor Ali Mirazimi at the Swedish Health Agency, the Karolinska Institute, and the Swedish National Veterinary Institute. The Paul-Ehrlich-Institut, which is the competent authority for the authorisation of clinical trials, marketing authorisations, and official batch control in Germany, will provide expert advice in regulatory aspects.

The Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, Island of Riems will assess the efficacies of newly developed animal vaccines by challenging cattle in the unique newly commissioned BSL4 high containment laboratory and animal facility. The third German partner involved is the Justus-Liebig University, which is specialised in vaccine design.

Horizon 2020

Horizon 2020 is the framework programme of the European Union for research and innovation. It promotes research, and as such, aims at developing a knowledge- and innovation-driven society and a competitive economy. At the same time it has the purpose of contributing to sustained development. In addition to the member states of the European Union, various other countries can participate in the Horizon 2020 program.


The Paul-Ehrlich-Institut, the Federal Institute for Vaccines and Biomedicines, in Langen near Frankfurt/Main is a senior federal authority reporting to the Federal Ministry of Health (Bundesministerium für Gesundheit, BMG). It is responsible for the research, assessment, and marketing authorisation of biomedicines for human use and immunological veterinary medicinal products. Its remit also includes the authorisation of clinical trials and pharmacovigilance, i.e. recording and evaluation of potential adverse effects.

Other duties of the institute include official batch control, scientific advice and inspections. In-house experimental research in the field of biomedicines and life science form an indispensable basis for the manifold tasks performed at the institute.

The Paul-Ehrlich-Institut, with its roughly 800 members of staff, also has advisory functions nationally (federal government, federal states (Länder)), and internationally (World Health Organisation, European Medicines Agency, European Commission, Council of Europe etc.).

Weitere Informationen:

http://fli.bund.de - FLI Friedrich-Loeffler-Institut
http://cordis.europa.eu/project/rcn/207211_en.html - CORDIS Project Information
https://www.uni-giessen.de/research/research-organizations/eu-projects/cooperati... - CCHFV-Projekt Info of Justus Liebig University Gießen

Dr. Susanne Stöcker | idw - Informationsdienst Wissenschaft

More articles from Life Sciences:

nachricht A novel synthetic antibody enables conditional “protein knockdown” in vertebrates
20.08.2018 | Technische Universität Dresden

nachricht Climate Impact Research in Hannover: Small Plants against Large Waves
17.08.2018 | Leibniz Universität Hannover

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: It’s All in the Mix: Jülich Researchers are Developing Fast-Charging Solid-State Batteries

There are currently great hopes for solid-state batteries. They contain no liquid parts that could leak or catch fire. For this reason, they do not require cooling and are considered to be much safer, more reliable, and longer lasting than traditional lithium-ion batteries. Jülich scientists have now introduced a new concept that allows currents up to ten times greater during charging and discharging than previously described in the literature. The improvement was achieved by a “clever” choice of materials with a focus on consistently good compatibility. All components were made from phosphate compounds, which are well matched both chemically and mechanically.

The low current is considered one of the biggest hurdles in the development of solid-state batteries. It is the reason why the batteries take a relatively long...

Im Focus: Color effects from transparent 3D-printed nanostructures

New design tool automatically creates nanostructure 3D-print templates for user-given colors
Scientists present work at prestigious SIGGRAPH conference

Most of the objects we see are colored by pigments, but using pigments has disadvantages: such colors can fade, industrial pigments are often toxic, and...

Im Focus: Unraveling the nature of 'whistlers' from space in the lab

A new study sheds light on how ultralow frequency radio waves and plasmas interact

Scientists at the University of California, Los Angeles present new research on a curious cosmic phenomenon known as "whistlers" -- very low frequency packets...

Im Focus: New interactive machine learning tool makes car designs more aerodynamic

Scientists develop first tool to use machine learning methods to compute flow around interactively designable 3D objects. Tool will be presented at this year’s prestigious SIGGRAPH conference.

When engineers or designers want to test the aerodynamic properties of the newly designed shape of a car, airplane, or other object, they would normally model...

Im Focus: Robots as 'pump attendants': TU Graz develops robot-controlled rapid charging system for e-vehicles

Researchers from TU Graz and their industry partners have unveiled a world first: the prototype of a robot-controlled, high-speed combined charging system (CCS) for electric vehicles that enables series charging of cars in various parking positions.

Global demand for electric vehicles is forecast to rise sharply: by 2025, the number of new vehicle registrations is expected to reach 25 million per year....

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

LaserForum 2018 deals with 3D production of components

17.08.2018 | Event News

Within reach of the Universe

08.08.2018 | Event News

A journey through the history of microscopy – new exhibition opens at the MDC

27.07.2018 | Event News

 
Latest News

Quantum bugs, meet your new swatter

20.08.2018 | Information Technology

A novel synthetic antibody enables conditional “protein knockdown” in vertebrates

20.08.2018 | Life Sciences

Metamolds: Molding a mold

20.08.2018 | Information Technology

VideoLinks
Science & Research
Overview of more VideoLinks >>>